CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

FDA Drugs (New Approvals & NDA)
Original article

PDUFA VIII: Fiscal Years 2028 – 2032

RegulatoryNeutral
AI Analysis

Summary

FDA announces preparation for the seventh reauthorization of PDUFA (Prescription User Fee Act) covering fiscal years 2028-2032. This is a routine regulatory announcement regarding user fee program reauthorization.

Importance:2/10
Sentiment:
0.00
PDUFAFDAReauthorizationRegulatory

Read the original article

Published by FDA Drugs (New Approvals & NDA) on April 9, 2026 2:39 PM

Read Original